The peptides associated with tendon and ligament injuries are mainly BPC-157 and TB-500. The results used to describe them come almost entirely from animal studies. There are no large clinical trials confirming that either of them speeds up the healing of an injury in humans, and no doses of proven effectiveness have been established.
On top of that, both are prohibited in sport at all times. This article collects what is known about peptides and injuries, and what is not. The molecules themselves are covered in the articles on BPC-157 and on recovery peptides.
Which peptides are linked to tendon and ligament healing?
In the context of soft tissue injury two peptides are named most often. BPC-157 is a peptide of 15 amino acids based on a protein found in gastric juice. TB-500 is a short fragment of thymosin beta-4, a protein involved in cell migration and blood vessel formation. In the shop they are stocked separately, as BPC-157 and TB-500, and as a ready BPC-157 and TB-500 blend. Why the two are combined is explained in a separate article.
What do the animal studies show?
In animal models BPC-157 accelerated the healing of a transected Achilles tendon, of damaged muscle and of ligaments. TB-500, or more precisely its parent molecule, has been linked to cell migration and the formation of blood vessels in healing tissue. These are promising signals, but they come from studies in rats and cell cultures, not from clinical trials.
What is known from human studies?
The human data are very thin. For BPC-157 they amount to one small observational study concerning knee pain, in a group of 16 people. For the TB-500 fragment no completed efficacy studies in humans had been published as of April 2026. Phase three trials were run for full thymosin beta-4, but in ophthalmology, in the form of eye drops.
Will peptides replace rehabilitation?
There is no basis for assuming so. The effectiveness of peptides in healing injuries in humans has not been demonstrated, while progressive loading and rehabilitation under the eye of a physiotherapist have a documented effect. A peptide is not an alternative to that process; it is a molecule without clinical confirmation. The whole group of recovery peptides is collected in the recovery peptides category.
What does an athlete risk by reaching for them?
A competitor under anti-doping control risks a ban of several years, because BPC-157 and TB-500 are on the World Anti-Doping Agency list at all times. A sanction can be imposed even without a positive test. Added to that is uncertainty about the composition of a preparation sold as research material. How that prohibition works is described in the article on the ban on BPC-157 and TB-500 in sport.
Frequently asked questions
Do BPC-157 or TB-500 heal tendon injuries in humans?
That has not been demonstrated in clinical trials. The data on the effect of these peptides on tendon healing come from animal studies and cell cultures.
Are there human studies of peptides for injuries?
For BPC-157 there is one small observational study concerning knee pain. For the TB-500 fragment there are no completed efficacy studies in humans.
Will peptides replace physiotherapy after an injury?
There is no evidence for that. Progressive loading and rehabilitation have a documented effect; peptides do not.
Can an athlete use these peptides?
Not in sport under anti-doping control. BPC-157 and TB-500 are prohibited at all times, and a ban can be imposed without a positive test.
Where this information comes from
The data on BPC-157 come from a review published by inPharmD and from material of the Maryland Orthopedic Specialists practice. That is the source of the statement that the evidence for an effect of BPC-157 on muscle and tendon healing is limited to studies in rats and cell cultures, and that one human study exists, in 16 people.
The data on TB-500 come from material published by Superpower on 2 August 2026: no completed efficacy studies for the fragment, phase three trials only for full thymosin beta-4 in ophthalmology. The status of both peptides on the World Anti-Doping Agency list comes from material published by BSCG in February 2026. These pages were checked on 31 August 2026.